The consortium of European industrial, scientific and medical partners met last week in Vienna, Austria, for their 6-month progress review on the MERLIN project. A real synergy between clinicians and scientists arised as the partners shared their latest advances on:
- Optical coherence tomography (OCT),
- Adaptive Optics imaging,
- Image registration,
- System integration.
The partners are developing a cutting-edge medical imaging instrument combining those technologies. It will enable fast, contactless examinations of the back of the eye, with a level of detail that is currently unavailable to doctors. With this device, the MERLIN project addresses unmet clinical needs in a wide range of sight-threatening pathologies, including age-related macular degeneration (AMD) and diabetes.
The project has received € 4.868M in funding from the European Union’s Horizon 2020 research and innovation program, under grant agreement No 780989. It unites the following partners:
- Imagine Eyes SA (France, project coordinator),
- the Medical University of Vienna (Austria),
- the ICFO the Institute of Photonics Sciences (Spain),
- the Erasmus Medical Center’s Biomedical Imaging Group Rotterdam (Netherlands),
- the INSERM at Quinze-Vingts National Eye Hospital (France),
- the Rigshospitalet in Copenhagen (Denmark).
Next review meeting will be held in Barcelona, Spain, in early December 2018.